Global Health Limited Holds 22nd AGM on Sep 16, 2026, Approves Dividend
Global Health Limited held its 22nd AGM on September 16, 2026. The company declared a final dividend of ₹0.50 per equity share for FY 2025-26. The audited financial statements for the year ended March 31, 2026, were adopted. Mr. Pankaj Sahni was re-elected as a director.
The announcement pertains to the Annual General Meeting and routine corporate actions such as dividend declaration and director re-election. These events are standard for a listed company and are unlikely to have a significant immediate impact on the company's stock price or operations.
The announcement reports on the proceedings of the Annual General Meeting, including the adoption of financial statements and the declaration of a dividend. These are routine corporate actions and do not indicate a significant positive or negative development for the company.
Global Health Limited (MEDANTA) held its 22nd Annual General Meeting (AGM) on September 16, 2026, commencing at 12 Noon through Video Conferencing (VC)/Other Audio Visual Means (OAVM). The meeting was conducted in compliance with applicable provisions of the Companies Act, 2013, and SEBI regulations.
Remote e-voting was available to members from September 12, 2026, 9:00 A.M. (IST) to September 15, 2026, 5:00 P.M. (IST), with an additional e-voting facility provided during the AGM. The company engaged NSDL for the VC/OAVM facility.
Dr. Naresh Trehan, Chairman, welcomed attendees and expressed gratitude for shareholder support, highlighting the company's commitment to healthcare excellence. Mr. Pankaj Sahni, Group CEO & Director, presented the financial and operational achievements for FY 2025-26.
The AGM transacted several items, including the adoption of Audited Standalone and Consolidated Financial Statements for the year ended March 31, 2026, the declaration of a final dividend of ₹0.50 per Equity Share, the re-election of Mr. Pankaj Sahni as Director, and the approval of remuneration for the Cost Auditors, M/s. Ramanath Iyer & Co., for FY 2026-27.
The Auditors' Report on Financial Statements and Secretarial Audit Report for FY ended March 31, 2026, had no qualifications. Voting results will be disseminated by September 18, 2026, on the company's website and NSDL's e-voting portal. The meeting concluded at 01:13 P.M.
What to do with a filing like this
Global Health Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Global Health Limited. Read the original for the full detail.